Clinical Trial Update: Ocriplasmin Research to Better Inform Treatment (ORBIT)

View source ↗

Summary

The ORBIT trial evaluating ocriplasmin for symptomatic vitreomacular adhesion has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Vitreomacular Adhesion

Drugs mentioned

• Jetrea (ocriplasmin)

Snippet

Sponsor: ThromboGenics | Conditions: Symptomatic Vitreomacular Adhesion | Status: COMPLETED